Participants 0 109 6
Efficacy of venlafaxine XR for the treatment of pain in patients with spinal cord injury and major depression
Participants 224 421 7
pain (secondary aim) in individuals with spinal cord injury (SCI) enrolled in a randomized controlled trial (RCT) on the efficacy of venlafaxine XR for major depressive disorder (MDD) (primary aim)
Participants 831 962 7
Individuals (N=123) with SCI and major depression between 18 and 64 years of age, at least 1 month post-SCI who also reported pain.
